ClinicalTrials.Veeva

Menu

Validation of the French Version of the Sydney Swallow Questionnaire in Patients With Neuromuscular Diseases

C

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Status

Completed

Conditions

Dysphagia
Neuromuscular Diseases

Treatments

Other: Sydney Swallow Questionnaire

Study type

Interventional

Funder types

Other

Identifiers

NCT02845362
2016/18MAI/215 (Other Identifier)
SSQVAL

Details and patient eligibility

About

Measurements of dysphagia severity are important when making management decisions and in the objective evaluation of swallowing impairments. The Sydney Swallow Questionnaire (SSQ) is a validated self-report inventory using a visual analogue scale. This questionnaire permits a quantitative, sensitive, specific, repeatable and easily responsive evaluation of dysphagia in different pathology. Opposed to largely used videofluoroscopy swallowing study and endoscopy examinations, the SSQ is noninvasive, less expensive, avoids radiation exposure and enables a readily available assessment. Validated French version is not yet available. In the first phase of the study the investigators will validated this translation in dysphagic patients and control. Secondly, the investigators will validate the SSQ in Neuromuscular patients.

Enrollment

250 patients

Sex

All

Ages

Under 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Phase 1:

Group 1:

  • Healthy participants
  • Able to speak, read and write in French
  • Aged at least 18 years old

Group 2:

  • Patients, with symptoms indicative of a deglutition disorder, referred for a videofluoroscopic study to the Otolaryngology, Head and Neck Surgery Department, Voice and Swallowing Clinic
  • Able to speak, read and write in French
  • Aged at least 18 years old

Phase 2:

  • Clinical diagnosis of neuromuscular diseases
  • Able to understand French

Exclusion criteria

Phase 1:

Group 1:

  • History of neurological or neuromuscular disease
  • History of any diagnosticated swallowing disorder

Group 2:

  • Patients who could not be cataloged as dysphagic or non-dysphagic after the videofluoroscopic study evaluation
  • Patients unable to answer the questionnaire

Phase 2:

  • Patients who could not be cataloged as dysphagic or non-dysphagic
  • Patients unable to answer the questionnaire

Trial design

Primary purpose

Screening

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

250 participants in 1 patient group

Dysphagia assessment
Experimental group
Treatment:
Other: Sydney Swallow Questionnaire

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems